Customer Service:
Mon - Fri: 8:30 am - 6 pm EST

 Most recent

ISO 10993-17:2002

Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances

ISO 10993-17:2002 specifies the determination of allowable limits for substances leachable from medical devices. It is intended for use in deriving standards and estimating appropriate limits where standards do not exist. It describes a systematic process through which identified risks arising from toxicologically hazardous substances present in medical devices can be quantified.

ISO 10993-17:2002 is not applicable to devices that have no patient contact (e.g. in vitro diagnostic devices).

Exposure to a particular chemical substance may arise from sources other than the device, such as food, water or air. ISO 10993-17:2002 does not address the potential for exposure from such sources.


Content Provider
International Organization for Standardization [ISO]


Others Also Bought

ISO 10993-18:2005
Biological evaluation of medical devices - Part 18: Chemical characterization of materials
ISO 10993-10:2002
Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity
ISO 10993-1:2003
Biological evaluation of medical devices - Part 1: Evaluation and testing
ANSI Logo

As the voice of the U.S. standards and conformity assessment system, the American National Standards Institute (ANSI) empowers its members and constituents to strengthen the U.S. marketplace position in the global economy while helping to assure the safety and health of consumers and the protection of the environment.

CUSTOMER SERVICE
NEW YORK OFFICE
ANSI HEADQUARTERS